- A two-round modified Delphi consensus study of 35 experts, 33 of them anesthesiologists from 17 countries, addressed adults with recent concussion having noncardiac extracranial surgery.
- The panel rated statements on a five-point Likert scale, with consensus defined a priori as at least 75% agreement and strong consensus as at least 85%.
- Of 16 Round 2 statements, 13 reached consensus, including unanimous agreement on preoperative screening and avoiding hypoxemia, hypotension, and marked hypertension, and strong consensus (97%) for generally deferring elective surgery until symptoms resolve.
- Consensus was not reached for regional or monitored anesthesia care over general anesthesia (74%), EEG-guided depth monitoring (73%), or cautious long-acting neuraxial opioid use (69%); the authors describe the output as an expert-informed framework, not an evidence-based guideline.
Neuro
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
- Ambidirectional cohort of 77 children aged 9-11, with or without prior surgical general anesthesia exposure, tested on a cognitive battery.
- Eight measures covered inhibitory control, cognitive flexibility, working memory, and visuo-spatial attention, analyzed with mixed-effects and exploratory latent profile models.
- No overall exposure effect on executive function (χ²(1)=.01, p=.92), but exposure was linked to lower odds of the Efficient profile (OR 0.71, 95% CI [0.705, 0.710], p<.001).
- Exposed children showed higher global-local precedence (estimate 0.53, 95% CI [0.04, 1.01], p=.036), which the authors describe as a possible post-operative phenotype.
- A Bayesian systematic review and meta-analysis of 54 studies, including 367,896 critically ill adults, examined new-onset atrial fibrillation in general ICUs and high-dependency units.
- It compared post-discharge systemic thromboembolism in patients with and without new-onset atrial fibrillation, with follow-up ranging from 1.5 months to 5 years.
- Pooled NOAF incidence was 10.6% (95% CrI 8.6-12.9%), and post-discharge thromboembolism risk was 7.1% (95% CrI 4.5-11.0%). Relative risk was 1.94 (95% CrI 1.23-3.29) across six studies, rising to 2.01 with adjustment.
- Anticoagulation use was low, at 32.9% in-hospital and 35.9% post-discharge, and 23.9% of patients with NOAF were later diagnosed with atrial fibrillation.
- Single-center, randomized, double-blind, placebo-controlled pilot trial of 100 critically ill adults with CAM-ICU-confirmed delirium in surgical and trauma ICUs.
- Patients received 2 mg guanfacine or matching placebo nightly for up to 14 days, or until ICU discharge or delirium resolution.
- Median delirium and coma-free days were 2 (IQR 0-6) with guanfacine versus 1 (IQR 0-4) with placebo (p = 0.02) in unadjusted analyses, but not significant after adjustment.
- Feasibility targets were mostly met, with 100% adherence, retention, and data completeness, though COVID-19 limited recruitment to 0.9 patients/week; authors judge the signal worth a multicenter trial.
- This methods paper uses data from the MENDS trial to examine composite endpoints for critical care delirium trials.
- It evaluates two existing composites: delirium- and coma-free days, and a ranked endpoint that treats death as worst and orders delirium- and coma-free days among survivors.
- The authors describe how to define treatment effects on each composite, assess their clinical interpretability, and visualize how effects accumulate over follow-up.
- They provide practical recommendations for composite endpoints that could extend to other randomized trials using similar endpoints.
- Multicenter prospective cohort of 480 adults with sepsis plus shock and/or acute respiratory failure, enrolled in medical and surgical ICUs in Nashville, TN.
- Plasma ccf-mtDNA was measured on study days 1, 3, and 5 and related to delirium and coma; no intervention was given.
- Higher ccf-mtDNA was associated with lower odds of delirium (OR 0.93, 95% CI 0.86-0.99; p = 0.048), but not with coma or 3- or 12-month cognition.
- Mortality association was marginal (HR 1.09, 95% CI 0.99-1.20; p = 0.08); the authors urge cautious interpretation until the finding is replicated.
- This scoping review of 130 studies, mostly observational cohorts (83.8%), mapped literature on chronic preoperative benzodiazepine use and perioperative outcomes.
- Chronic use was defined inconsistently, ranging from 1 month to over 1 year before surgery, and duration was not systematically defined in 47.7% of studies.
- Postoperative opioid use (40.8% of studies) and delirium or cognitive impairment (14.6%) were the most examined outcomes, with most reporting adverse associations.
- The authors conclude chronic use is a clinically relevant but inconsistently defined exposure, and that causal inference is not possible without risk-of-bias assessment and prospective studies.
- In a prospective multicentre observational study of 2442 adult surgical patients at 43 Spanish hospitals, 1899 completed 1-year telephone follow-up.
- The exposure was postoperative delirium within 48 hours, screened with CAM, CAM-ICU or the telephone-administered 4AT depending on setting.
- Delirium was independently associated with a 4.60-point higher WHODAS 2.0 score at 1 year (95% CI 1.57 to 7.64, P = 0.003), and with institutionalisation (OR 2.5, 95% CI 1.07 to 5.84, P = 0.03).
- Mortality was 16.7% versus 3.1% (P < 0.001), and the authors conclude that delirium is a key perioperative complication that supports prevention and structured long-term follow-up.
- This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
- It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
- Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
- The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
- Scoping review (PRISMA-ScR) of 48 included studies from 1,342 screened, mostly US-based and retrospective (43/48).
- Included studies examined GLP-1 receptor agonist exposure in adults with spinal, intracranial, or cerebrovascular disease, grouped into three themes.
- Spinal fusion studies repeatedly linked perioperative exposure to lower pseudarthrosis, though some reported more postoperative complications; IIH studies linked it to lower papilledema and shunt placement.
- The authors judge benefit signals most consistent in spinal fusion and IIH, but adverse effects and database overlap limit causal inference, and they call for prospective trials.
- Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
- Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
- Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
- Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
- Systematic review and meta-analysis of 87 RCTs enrolling 30,611 adults undergoing surgical, endoscopic, or dental procedures.
- Compared pEEG-guided with non-pEEG-guided anesthesia on anesthetic drug use, postoperative delirium, and perioperative efficiency measures.
- pEEG reduced propofol use (SMD -0.42) and volatile agent use (SMD -1.27), and postoperative delirium risk fell (RR 0.73, 95% CI 0.63 to 0.84).
- Extubation, wake-up, orientation, and PACU stay were all shorter with pEEG, with BIS showing the most consistent benefit and substantial heterogeneity for several outcomes.
- Single-centre, double-blind randomised noninferiority trial of 686 adults having elective neurovascular surgery, analysed as a modified intention-to-treat population.
- Patients received remimazolam-based TIVA with flumazenil reversal at emergence or propofol-based TIVA, both with remifentanil.
- Postoperative delirium within 5 days occurred in 12.8% (44/344) with remimazolam and 10.8% (37/342) with propofol; risk difference 1.97 percentage points (95% CI -2.85 to 6.80).
- Remimazolam met the prespecified noninferiority criterion, and that group had less intraoperative hypotension below a MAP of 65 mm Hg and more operating-room extubation.
- Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
- Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
- Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
- The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
- Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
- Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
- No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
- The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
- This structured narrative review synthesizes adult postoperative delirium evidence across the perioperative pathway, searching major databases plus ESAIC and ASA resources and reference lists.
- It classifies prevention and therapeutic strategies by clinical maturity, target population, and implementation readiness rather than by pooled effect size.
- The authors report that no single anesthetic technique, processed-EEG target, blood-pressure threshold, cerebral oximetry strategy, or agent consistently prevents delirium across surgical populations.
- Multicomponent non-pharmacological prevention has the most consistent support, dexmedetomidine appears context-dependent, and biomarkers and metabolic targets remain investigational.
- Systematic review and meta-analysis of 13 RCTs including 1446 patients comparing preoperative cognitive training with usual care.
- Primary outcomes were postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder.
- Training was associated with lower postoperative delirium risk (RR 0.53, 95% CI 0.36-0.77, P=0.001), though certainty was rated low.
- The delayed neurocognitive recovery reduction (RR 0.66, 95% CI 0.46-0.96) was not robust to sensitivity analyses, and traditional training may outperform digital training for delirium.
- Prospective exploratory observational study of 83 elderly patients from one tertiary hospital under sevoflurane anesthesia with 19-channel EEG, after 17 excluded for artifacts.
- Exposure was EEG alpha anteriorization and network efficiency across induction, maintenance, emergence, and PACU phases, compared between patients with and without postoperative delirium.
- Just before loss of responsiveness, nondelirium patients showed frontal alpha power of 4.24 vs -0.88 dB (P = .007), whereas delirium patients showed minimal change.
- During maintenance, the delirium group had longer averaged characteristic path lengths (4.49 ± 0.62 vs 3.57 ± 0.16, P = .026, FDR-corrected), suggesting reduced network efficiency.
- This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
- Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
- Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
- The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.
- Retrospective PearlDiver Mariner database study of patients with type 2 diabetes on metformin who underwent posterior cervical surgery from 2010 to 2023, using propensity-score matching.
- Preoperative GLP-1 receptor agonist users were compared with matched non-users and with patients who had prior bariatric surgery.
- GLP-1 users had lower odds of perioperative pneumonitis (OR 0.57; 95% CI 0.43-0.75; p<0.001) and of 90-day revision surgery (OR 0.33; 95% CI 0.29-0.36; p<0.001).
- Lower odds persisted for 2-year revision surgery and nutritional deficiency, and no significant differences were found versus the bariatric surgery cohort.
- Prospective cohort substudy of adults undergoing hip or knee arthroplasty, measuring plasma and CSF brain-derived tau before neuraxial anaesthesia and up to 48 h after surgery.
- Plasma brain-derived tau peaked at 4 h with a 254% rise (IQR 137-382%, P<0.001) and was still 31% above baseline at 48 h (6-75%, P<0.001).
- CSF brain-derived tau was unchanged at 4 h but rose 51% by 48 h (21-82%, P=0.004), and plasma and CSF levels were inversely associated (β=-0.71, P<0.001).
- The authors suggest the early plasma rise reflects redistribution of tau from the CNS rather than concomitant neuronal injury; higher plasma levels were also associated with worse cognition at 3 months.